[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.48.3. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
August 15, 2007

HPV Vaccines—Prophylactic, Not Therapeutic

Author Affiliations
 

Author Affiliation: National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.

JAMA. 2007;298(7):805-806. doi:10.1001/jama.298.7.805

Two human papillomavirus (HPV) L1 viruslike particle (VLP) vaccines have been developed against HPV types 16 and 18—the 2 HPV types that account for about 70% of cervical cancers worldwide.1 Both vaccines have been found to have high prophylactic efficacy in large clinical trials.26

First Page Preview View Large
First page PDF preview
First page PDF preview
×